AstraZeneca earnings Q2 2026 beat analyst expectations as core EPS hit $2.63 versus a $2.48 consensus, with oncology revenue ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results